Welcome. MP Healthcare Venture Management (MPH)
is a Boston-based lifesciences venture capital firm passionate about connecting ideas, technologies, and business processes to create tomorrow’s healthcare innovations. Find out how connecting with MPH can get your ideas to market faster and bring value to your vision. More

News and Events

9 January 2014

F-star achieves milestone in collaboration with Boehringer Ingelheim.More

23 December 2013

Genocea Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering.More

9 December 2013

Covagen Secures CHF 42 Million in Series B Financing.More

6 December 2013

Covagen and Tanabe Research Laboratories Expand Strategic Research Collaboration for Development of Bispecific FynomAbs.More

5 December 2013

Genocea Biosciences Initiates Phase 1 Study of Vaccine Candidate Gen-004 to Prevent Infections Caused by Pneumococcus.More

23 October 2013

F-star announces formation of new asset-centric vehicle, F-star Alpha Ltd,
with €9.4m Series A investment.More


Featured Portfolio